(CNN) A drug normally prescribed to treat multiple sclerosis helped reduce the risk of severe disease from Covid-19, British researchers reported Thursday. In the trial, SNG001 was administered to 48 patients using a nebulizer while 50 patients received the placebo. Then by the 28th day, 58% in the SNG001 group had recovered compared with 35% in the placebo group. Overall, three patients died during the study and all were in the placebo group. The researchers also found that 11 patients -- or 22% -- in the placebo group developed severe disease by day 16 compared with six patients -- or 13% -- in the SNG001 group.

Source: CNN November 12, 2020 23:37 UTC